ShopSpell

Safety, Ethics and Regulations [Hardcover]

$119.99     $169.99    29% Off      (Free Shipping)
100 available
  • Category: Books (Science)
  • ISBN-10:  3319591649
  • ISBN-10:  3319591649
  • ISBN-13:  9783319591643
  • ISBN-13:  9783319591643
  • Publisher:  Springer
  • Publisher:  Springer
  • Binding:  Hardcover
  • Binding:  Hardcover
  • Pub Date:  01-Apr-2017
  • Pub Date:  01-Apr-2017
  • SKU:  3319591649-11-SPRI
  • SKU:  3319591649-11-SPRI
  • Item ID: 100878581
  • List Price: $169.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Jul 11 to Jul 13
  • Notes: Brand New Book. Order Now.
This invaluable resource discusses the saftey, ethics, and regulations of developing stem cell clinical applications. Each chapter is contributed by a preeminent scientist in the field and covers such topics as clinical safety of stem cell gene therapy, the patentability of hESC technologies, international guidelines, challenges to international stem cell clinical trials, worldwide regulations including in emerging markets like China and Taiwan.

Saftey, Ethics, and Regulations ?and the other books in the ?Stem Cells in Clinical Applications? series will be invaluable to scientists, researchers, advanced students and clinicians working in stem cells, regenerative medicine or tissue engineering.

Part ?I. Safety .- Chapter 1: The safety of allogeneic stem cell transplantation .- Chapter 2: Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-related Chronic Neurodegenerative Diseases .- Chapter 3: IClinical safety and applications of stem cell gene therapy .- Chapter 4: ?The safety of non-expanded multipotential stromal cell therapies.- Part ?II: Ethics and Regulations .- Chapter 5: A Normative Case for the Patentability of Human Embryonic Stem Cell Technologies .- Chapter 6. Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions .- Chapter 7. New Regulatory Pathways for Stem Cell-Based Therapies: Comparison and Critique of Potential Models.- Chapter 8: Travelling cells  Harmonised European Regualtion and the BAMI stem cell trial.- Chapter 9: Oversight and Evidence in Stem Cell Innovation: An Examination of International Guidelines.- Chapter 10: The regulation of clinical stem cell research in China .- Chapter 11: Gov

erning Stem Cell Therapies in India.- Chapter 12: Patenting human embryonic stem cells in the European Union context: an updated analysis of a complex issue.- Chapter 13: The regulatorl#J
Add Review